PMID- 29329878 OWN - NLM STAT- MEDLINE DCOM- 20180220 LR - 20180220 IS - 1879-3169 (Electronic) IS - 0378-4274 (Linking) VI - 286 DP - 2018 Apr TI - Course-, dose-, and stage-dependent toxic effects of prenatal dexamethasone exposure on fetal articular cartilage development. PG - 1-9 LID - S0378-4274(18)30008-0 [pii] LID - 10.1016/j.toxlet.2018.01.008 [doi] AB - Dexamethasone, a synthetic long-acting glucocorticoid, is routinely used for treating mothers at risk for preterm delivery. However, intrauterine overexposure to glucocorticoids induces low birth weight and cartilage dysplasia in offspring. Also, the "critical window" and safe dose of this treatment are largely unknown. This study investigated the course-, dose-, and stage-dependent toxic effects and the possible mechanisms of prenatal dexamethasone exposure (PDE) on fetal development and articular cartilage development. Pregnant mice (C57BL/6) received subcutaneous injection of dexamethasone (0.8 mg/kg d) once on gestational day (GD) 15 or once a day from GD 15 to 17, or received various doses of dexamethasone (0, 0.2, 0.8, and 1.2 mg/kg d) on GD 15-17, or received dexamethasone (0.8 mg/kg d) at early stage (GD 12-14) or late stage of pregnancy (GD 15-17). Offspring's knee joints were harvested at birth for morphological analyses and detection of gene expression. Repeated PDE significantly suppressed fetal and articular cartilage development, which were characterized by decreased body weight and body length, coarse articular cartilage surfaces, and reduced gene and protein expression of Col2a1 and aggrecan. For those newborns treated with repeated PDE at different doses, the toxic effects on fetal and articular cartilage development were observed at doses of 0.8 and 1.2 mg/kg d, whereas no obvious toxic effects were observed at the dose of 0.2 mg/kg d. Moreover, PDE at 0.8 mg/kg d during the early embryonic stage induced stronger toxic effects on fetal and articular cartilage development, compared with PDE during the late embryonic stage. Detection of gene expression showed that the TGFbeta signaling pathway in the articular cartilage was down-regulated after PDE. Taken together, PDE induces fetal developmental toxicity and articular cartilage developmental toxicity in a course-, dose-, and stage-dependent manner. CI - Copyright (c) 2018 Elsevier B.V. All rights reserved. FAU - Chen, Ze AU - Chen Z AD - Department of Pharmacology, Basic Medical School of Wuhan University, No.185 Donghu Road, Wuhan, Hubei Province, 430071, China. FAU - Zhao, Zhe AU - Zhao Z AD - Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, No.169 Donghu Road, Wuhan, Hubei Province, 430071, China. FAU - Li, Yunzepeng AU - Li Y AD - Department of Pharmacology, Basic Medical School of Wuhan University, No.185 Donghu Road, Wuhan, Hubei Province, 430071, China. FAU - Zhang, Xingyu AU - Zhang X AD - Department of Pharmacology, Basic Medical School of Wuhan University, No.185 Donghu Road, Wuhan, Hubei Province, 430071, China. FAU - Li, Bin AU - Li B AD - Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, No.169 Donghu Road, Wuhan, Hubei Province, 430071, China. FAU - Chen, Liaobin AU - Chen L AD - Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, No.169 Donghu Road, Wuhan, Hubei Province, 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disease, No.185 Donghu Road, Wuhan, Hubei Province, 430071, China. Electronic address: lbchen@whu.edu.cn. FAU - Wang, Hui AU - Wang H AD - Department of Pharmacology, Basic Medical School of Wuhan University, No.185 Donghu Road, Wuhan, Hubei Province, 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Disease, No.185 Donghu Road, Wuhan, Hubei Province, 430071, China. Electronic address: wanghui19@whu.edu.cn. LA - eng PT - Comparative Study PT - Journal Article DEP - 20180110 PL - Netherlands TA - Toxicol Lett JT - Toxicology letters JID - 7709027 RN - 0 (Aggrecans) RN - 0 (Col2a1 protein, mouse) RN - 0 (Collagen Type II) RN - 0 (Glucocorticoids) RN - 0 (Transforming Growth Factor beta) RN - 7S5I7G3JQL (Dexamethasone) SB - IM MH - Aggrecans/genetics/metabolism MH - Animals MH - Cartilage, Articular/*drug effects/embryology/metabolism MH - Chondrogenesis/*drug effects MH - Collagen Type II/genetics/metabolism MH - Dexamethasone/administration & dosage/*toxicity MH - Dose-Response Relationship, Drug MH - Female MH - Fetus/*drug effects/metabolism/pathology MH - Gene Expression Regulation, Developmental/drug effects MH - Gestational Age MH - Glucocorticoids/administration & dosage/*toxicity MH - Maternal Exposure MH - Mice, Inbred C57BL MH - Pregnancy MH - Risk Assessment MH - Signal Transduction/drug effects MH - Transforming Growth Factor beta/genetics/metabolism OTO - NOTNLM OT - Articular cartilage development OT - Developmental toxicity OT - Dexamethasone OT - Prenatal exposure OT - Transforming growth factor beta EDAT- 2018/01/14 06:00 MHDA- 2018/02/21 06:00 CRDT- 2018/01/14 06:00 PHST- 2017/09/23 00:00 [received] PHST- 2017/12/17 00:00 [revised] PHST- 2018/01/09 00:00 [accepted] PHST- 2018/01/14 06:00 [pubmed] PHST- 2018/02/21 06:00 [medline] PHST- 2018/01/14 06:00 [entrez] AID - S0378-4274(18)30008-0 [pii] AID - 10.1016/j.toxlet.2018.01.008 [doi] PST - ppublish SO - Toxicol Lett. 2018 Apr;286:1-9. doi: 10.1016/j.toxlet.2018.01.008. Epub 2018 Jan 10.